Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
In BriefThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine June 2014, 55 (6) 11A;
  • Article
  • Info & Metrics
  • PDF
Loading

Pediatric radiopharmaceutical guidelines: Treves and Lassmann provide commentary and background on the recent release of international harmonized recommendations on radiopharmaceutical administered activities in children.

Page 869

PET tau radiotracers: Shah and Catafau present an overview of current studies and developments in PET radiotracers as new-generation biomarkers targeting tau proteins in neurodegenerative disease.

Page 871

99Mo/99mTc supply diversification: Dick looks at efforts and projects underway to provide reliable and uninterrupted supplies of these essential radionuclides and previews an article in this issue of JNM on an alternative approach to 99mTc production.

Page 875

Adjuvant 131I-lipiodol in HCC: Dumortier and colleagues compare the effectiveness of a single dose of postoperative adjuvant intraarterial 131I-lipiodol with unlabeled lipiodol in reducing the rate of intrahepatic recurrence of hepatocellular carcinoma.

Page 877

Prognostic factors in H&N cancer: Pak and colleagues report on a systematic literature review of volumetric parameters and a metaanalysis of the prognostic value of metabolic tumor volume and total lesion glycolysis in patients with head and neck cancer.

Page 884

Tumor heterogeneity in rectal cancer: Bundschuh and colleagues investigate textural parameters from 18F-FDG PET/CT for their predictive and prognostic capabilities in patients with rectal cancer.

Page 891

MTV and TLG in pancreatic cancer: Lee and colleagues assess the prognostic value of metabolic tumor volume and total lesion glycolysis measured on 18F-FDG PET/CT in pancreatic cancer patients who underwent resection with curative intent.

Page 898

Imaging prostate cancer metastatic burden: Kwee and colleagues explore the prognostic significance of metabolically active tumor volume measurements from 18F-fluorocholine PET/CT in men with castration-resistant prostate cancer.

Page 905

PET/CT in NK/T-cell lymphoma therapy: Khong and colleagues determine the accuracy of midtreatment 18F-FDG PET response assessment in patients with newly diagnosed or relapsed histologically proven extranodal natural killer/T-cell lymphoma.

Page 911

SPECT, cardiac CT, and TID: Halligan and colleagues use cardiac CT to evaluate atherosclerotic lesions and the severity of coronary artery stenosis in patients with transient ischemic dilation of the left ventricle with or without SPECT myocardial perfusion defects.

Page 917

PET/MR and PET/CT in brain: Hitz and colleagues compare the qualitative performance and results of 18F-FDG imaging obtained with integrated PET/MR and conventional PET/CT in the same patients examined for assessment of cognitive impairment.

Page 923

11C-AZD2184 PET in AD: Ito and colleagues look at the binding and kinetic properties of this radioligand for amyloid senile plaques in individuals with Alzheimer disease and in control subjects.

Page 932

11C-PK11195 PET in SPMS: Rissanen and colleagues determine whether translocator protein imaging can be used to visualize diffuse inflammation in the periplaque area and in normal-appearing white matter in the brains of patients with secondary progressive multiple sclerosis.

Page 939

Neuroinflammation in CFS/ME: Nakatomi and colleagues use 11C-(R)-PK11195 PET to identify and characterize neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis.

Page 945

PET in OCD neurosurgery: Suetens and colleagues describe the utility of 18F-FDG PET in exploring mechanisms leading to clinical improvement in patients with obsessive–compulsive disorder who undergo capsulotomy or deep-brain stimulation interventions.

Page 951

11C-PHNO reproducibility in human brain: Gallezot and colleagues evaluate the reproducibility of binding parameters and test–retest variability with this agonist radioligand for PET imaging of dopamine receptors.

Page 960

Hepatobiliary scintigraphy: Ziessman provides an educational overview of current diagnostic uses of hepatobiliary scintigraphy, appropriate methodologies for performing cholescintigraphy for various clinical indications, related pharmacologic interventions, and image interpretation criteria.

Page 967

PET and GIP receptors: Gourni and colleagues describe the development and evaluation of a new class of radioligands with the potential to be used for in vivo targeting of glucose-dependent insulinotropic polypeptide receptor–positive tumors.

Page 976

PET and MR in lung cancer: Schelhaas and colleagues investigate the molecular and cellular determinants of 18F-FLT PET and diffusion-weighted MR imaging in lung carcinoma xenografts.

Page 983

Integrin αvβ6–targeted SPECT: Liu and colleagues detail the synthesis and in vitro and in vivo evaluation of a 99mTc-labeled peptide as a SPECT radiotracer for imaging of integrin αvβ6 expression.

Page 989

Dual-modality prostate imaging: Lütje and colleagues report on the potential of dual-modality prostate cancer imaging with the monoclonal antibody D2B, directed against an extracellular domain of prostate-specific membrane antigen, labeled with both 111In and a near-infrared fluorescent dye.

Page 995

Imaging EGFR downregulation: Ma and colleagues determine whether molecular imaging with near-infrared fluorescence and PET probes can sensitively detect trastuzumab-induced epidermal growth factor receptor downregulation in tumor-bearing mice.

Page 1002

99mTc-PNA imaging and EGFR mRNA: Zhao and colleagues describe a method for preparation of single-photon–emitting mRNA antisense peptide nucleic acid probes and evaluate their feasibility for imaging epidermal growth factor receptor mRNA overexpression in malignant tumors.

Page 1008

Cyclotron production of 99mTc: Bénard and colleagues report on the development of a comprehensive approach to production of 99mTc using a single medical cyclotron, with sufficient resulting quantities to supply a large urban area.

Page 1017

Ethanol-based 68Ga postprocessing: Eppard and colleagues describe the feasibility of a method for replacing acetone with ethanol in purification and concentration of generator-derived 68Ga.

Page 1023

Radiolabeled irreversible peptide: Marquez and colleagues evaluate a 64Cu-labeled affinity peptide tag that binds covalently and irreversibly to vascular endothelial growth factor as a PET imaging agent.

Page 1029

Optical imaging in RCC: Muselaers and colleagues study the potential of fluorescence imaging to detect clear-cell renal cell carcinoma tumors in nude mice using the chimeric monoclonal antibody girentuximab conjugated with a near-infrared dye.

Page 1035

  • © 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Next
Back to top

In this issue

Journal of Nuclear Medicine: 55 (6)
Journal of Nuclear Medicine
Vol. 55, Issue 6
June 1, 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Jun 2014, 55 (6) 11A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Jun 2014, 55 (6) 11A;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • Molecular Imaging Insights into Neurodegeneration: Focus on Tau PET Radiotracers
  • Optical Imaging of Renal Cell Carcinoma with Anti–Carbonic Anhydrase IX Monoclonal Antibody Girentuximab
  • Preparation and Evaluation of 99mTc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors
  • Integrin αvβ6–Targeted SPECT Imaging for Pancreatic Cancer Detection
  • Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Head and Neck Cancer: A Systematic Review and Meta-Analysis
  • Hepatobiliary Scintigraphy in 2014
  • Ethanol-Based Post-processing of Generator-Derived 68Ga Toward Kit-Type Preparation of 68Ga-Radiopharmaceuticals
  • Development of a Radiolabeled Irreversible Peptide Ligand for PET Imaging of Vascular Endothelial Growth Factor
  • In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand 11C-PK11195
  • Adjuvant Intraarterial Lipiodol or 131I-Lipiodol After Curative Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial
  • Parametric Imaging and Test–Retest Variability of 11C-(+)-PHNO Binding to D2/D3 Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner
  • Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3′-Deoxy-3′-18F-Fluorothymidine PET and Diffusion-Weighted MR Imaging
  • Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients with Pancreatic Cancer
  • Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for 18F-FDG Brain Imaging in Patients Examined for Suspected Dementia
  • Midtreatment 18F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center
  • Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An 11C-(R)-PK11195 PET Study
  • Prognosis Related to Metastatic Burden Measured by 18F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer
  • Differences in Metabolic Network Modulation Between Capsulotomy and Deep-Brain Stimulation for Refractory Obsessive-Compulsive Disorder
  • Molecular Imaging Reveals Trastuzumab-Induced Epidermal Growth Factor Receptor Downregulation In Vivo
  • Transient Ischemic Dilation of the Left Ventricle on SPECT: Correlation with Findings at Coronary CT Angiography
  • Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody
  • Diversification of 99Mo/99mTc Supply
  • The Glucose-Dependent Insulinotropic Polypeptide Receptor: A Novel Target for Neuroendocrine Tumor Imaging—First Preclinical Studies
  • Implementation of Multi-Curie Production of 99mTc by Conventional Medical Cyclotrons
  • International Guidelines for Pediatric Radiopharmaceutical Administered Activities
  • Quantitative Analysis of Amyloid Deposition in Alzheimer Disease Using PET and the Radiotracer 11C-AZD2184
  • Textural Parameters of Tumor Heterogeneity in 18F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire